首页> 美国卫生研究院文献>New Microbes and New Infections >First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia 2009–2013
【2h】

First antimicrobial resistance data and genetic characteristics of Neisseria gonorrhoeae isolates from Estonia 2009–2013

机译:2009-2013年来自爱沙尼亚的淋病奈瑟菌分离株的首个抗菌素耐药性数据和遗传学特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gonorrhoea is a sexually transmitted infection with major public health implications and Neisseria gonorrhoeae has developed resistance to all antimicrobials introduced for treatment. Enhanced surveillance of antimicrobial resistance in N. gonorrhoeae is crucial globally. This is the first internationally reported antimicrobial resistance data for N. gonorrhoeae from Estonia (44 isolates cultured in 2009–2013). A high prevalence of resistance was observed for azithromycin, ciprofloxacin and tetracycline. One and two isolates with resistance and decreased susceptibility to the last remaining first-line treatment option ceftriaxone, respectively, were identified. It is crucial to implement surveillance of gonococcal antimicrobial resistance (ideally also treatment failures) in Estonia.
机译:淋病是一种性传播感染,对公共卫生有重大影响,淋病奈瑟氏球菌对引入治疗的所有抗菌药物均产生耐药性。在全球范围内加强对淋病奈瑟菌的耐药性监测至关重要。这是爱沙尼亚(2009-2013年培养的44种分离菌)首次公开报道的淋病奈瑟菌的抗药性数据。观察到阿奇霉素,环丙沙星和四环素的耐药率很高。分别鉴定出对最后一线治疗方案头孢曲松具有抗药性和敏感性降低的一株和两株。在爱沙尼亚实施对淋球菌抗菌素耐药性的监测(理想情况下也是治疗失败)至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号